About Qubit Pharmaceuticals
Qubit Pharmaceuticals is a company based in Paris (France) founded in 2020 by Jay Ponder, Piquemal, Louis Lagardere, Matthieu Montes, and Pengyu Ren. Qubit Pharmaceuticals has raised $17.2 million across 3 funding rounds from investors including EIT Health, European Union and XAnge. Qubit Pharmaceuticals offers products and services including Atlas, Sirius, TINKER-HP, and Hyperion. Qubit Pharmaceuticals operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Paris, France
- Founders Jay Ponder, Piquemal, Louis Lagardere, Matthieu Montes, Pengyu Ren
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$17.2 M (USD)
in 3 rounds
-
Latest Funding Round
$2.49 M (USD), Grant
Sep 01, 2022
-
Investors
EIT Health
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Qubit Pharmaceuticals
Qubit Pharmaceuticals offers a comprehensive portfolio of products and services, including Atlas, Sirius, TINKER-HP, and Hyperion.
Enables high-resolution simulations for drug candidate discovery and optimization.
Provides AI for generative and predictive modeling of small molecules.
Accelerates simulations using polarizable force fields for drug development.
Develops algorithms for quantum chemistry in drug discovery applications.
People of Qubit Pharmaceuticals
Unlock access to complete
Funding Insights of Qubit Pharmaceuticals
Qubit Pharmaceuticals has successfully raised a total of $17.2M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $2.49 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Qubit Pharmaceuticals
Qubit Pharmaceuticals has secured backing from 6 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include EIT Health, European Union and XAnge.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on tech companies
|
Locked | Locked | Locked | |
|
Quantonation is recognized as a venture capital fund focused on quantum and physics-based technologies.
|
Locked | Locked | Locked | |
|
Private equity firm focused on energy transition and sustainable investments across Europe.
|
Locked | Locked | Locked |
Investor details for Qubit Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Qubit Pharmaceuticals
Investment portfolio details for Qubit Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Qubit Pharmaceuticals
Detailed financials for Qubit Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Qubit Pharmaceuticals Comparisons
Peer comparison for Qubit Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Qubit Pharmaceuticals
Qubit Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
Dental implants and regenerative dentistry products are developed.
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
Detailed competitors of Qubit Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Qubit Pharmaceuticals
Complete news archive for Qubit Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Qubit Pharmaceuticals
Qubit Pharmaceuticals was founded in 2020.
Qubit Pharmaceuticals is headquartered in Paris, France.
Qubit Pharmaceuticals is a funded company, having raised a total of $17.2M across 3 funding rounds to date.
Qubit Pharmaceuticals was founded in 2020 in Paris, France, as a developer in the pharmaceutical sector. Novel drug candidates are created for oncology, inflammatory diseases, and pandemic response. Software and AI-enhanced medicinal chemistry are employed to support these efforts, focusing on targeted treatments within the biotechnology industry. Operations are centered in Europe, with an emphasis on computational drug discovery methods.
Qubit Pharmaceuticals's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Qubit Pharmaceuticals offers Atlas, Sirius, TINKER-HP, and Hyperion.
Qubit Pharmaceuticals has 6 investors. Key investors include EIT Health, European Union, XAnge, Quantonation, and Octave Klaba.